GlassScriptPhysician profile
Beshara Helou
NPI 1407811490
$143,390.68
in general payments reported to CMS, 2019-2025
69 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $18K · 2021: $20K · 2022: $22K · 2023: $7,658 · 2024: $13K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $9,270 · Consulting Fee: $8,614 · Travel and Lodging: $1,588 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,459.25 |
| Food and Beverage | $9,269.92 |
| Consulting Fee | $8,614.00 |
| Travel and Lodging | $1,588.12 |
| Education | $109.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $57,901.71 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $28,902.73 | 2019-2024 | Spravato |
| Lilly USA, LLC | $14,984.57 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Allergan, INC. | $10,806.60 | 2019-2021 | |
| Genzyme Corporation | $7,670.67 | 2024 | |
| Idorsia Pharmaceuticals US INC | $5,624.90 | 2022-2024 | Quviviq |
| Sanofi-Aventis U.S. LLC | $2,305.29 | 2020-2024 | |
| Abbvie INC. | $1,943.89 | 2019-2025 | |
| Pfizer INC. | $1,278.88 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,193.46 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,002.63 | 2019-2025 | Jardiance, Stiolto Respimat |
| Glaxosmithkline, LLC. | $919.03 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $717.55 | 2019-2025 | Otezla, Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $679.91 | 2019-2025 | |
| Astellas Pharma US INC | $560.35 | 2019-2025 | Veozah, Myrbetriq |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $462.86 | 2019-2025 | Gardasil 9, Verquvo, Capvaxive |
| Sunovion Pharmaceuticals INC. | $443.35 | 2019-2022 | |
| Amarin Pharma, INC. | $432.11 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $402.77 | 2020-2024 | Rexulti, Nuedexta, Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $377.95 | 2022-2025 | |
| Corcept Therapeutics | $370.07 | 2024-2025 | Korlym |
| Sumitomo Pharma America, INC. | $359.74 | 2023-2025 | Gemtesa |
| Dexcom, INC. | $319.46 | 2020-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $278.73 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $248.83 | 2019-2025 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $232.73 | 2019-2023 | Austedo |
| Lundbeck LLC | $222.05 | 2020-2025 | Rexulti |
| Scilex Pharmaceuticals INC. | $218.33 | 2019-2021 | |
| Esperion Therapeutics, INC. | $184.18 | 2022-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $180.91 | 2020-2025 | Zoryve, Seglentis |
| Avanir Pharmaceuticals, INC. | $179.32 | 2019-2022 | |
| Shield Therapeutics INC | $162.27 | 2024 | |
| Ardelyx, INC. | $161.83 | 2024-2025 | Ibsrela |
| Abbott Laboratories | $152.75 | 2020-2024 | Freestyle Libre 3 |
| Eisai INC. | $141.37 | 2020-2024 | |
| Sanofi Pasteur INC. | $131.68 | 2019-2025 | |
| Mylan Specialty L.P. | $109.99 | 2021-2024 | Yupelri |
| Biofire Diagnostics, LLC | $95.50 | 2019 | |
| Mallinckrodt Enterprises LLC | $94.40 | 2019 | |
| Phathom Pharmaceuticals, INC. | $86.38 | 2024-2025 | Voquezna |
| Globus Medical, INC. | $57.12 | 2025 | Senza |
| Genentech USA, INC. | $55.68 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.24 | 2019-2021 | |
| Brainsway USA INC | $50.23 | 2025 | Deep Tms System |
| Olympus America INC. | $47.80 | 2019 | |
| Bausch Health US, LLC | $46.72 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $44.36 | 2023 | Gvoke Hypopen |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.28 | 2025 | Caplyta |
| Horizon Therapeutics Plc | $40.59 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $40.04 | 2021 | |
| Amneal Pharmaceuticals LLC | $33.01 | 2019 | |
| Philips North America LLC | $30.62 | 2021 | |
| Medtronic, INC. | $27.98 | 2021 | |
| Supernus Pharmaceuticals, INC. | $23.36 | 2019 | |
| Insightec,INC | $23.00 | 2022 | |
| Pulmonx Corporation | $21.73 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Medicure Pharma INC. | $20.48 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.08 | 2022 | |
| Cmp Pharma, INC. | $18.03 | 2021 | |
| Tactile Systems Technology INC | $17.74 | 2025 | Nimbl, Flexitouch Plus |
| Alexion Pharmaceuticals, INC. | $17.49 | 2024 | Strensiq |
| Vertos Medical, INC. | $16.83 | 2024 | Mild Device Kit |
| Depuy Synthes Sales INC. | $16.74 | 2022 | |
| Tandem Diabetes Care, INC. | $16.00 | 2021 | |
| United Therapeutics Corporation | $14.90 | 2025 | Tyvaso |
| Biogen, INC. | $13.43 | 2023 | |
| Alkermes, INC. | $13.37 | 2019 | |
| Radius Health, INC. | $12.57 | 2020 | |
| Apria Healthcare LLC | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beshara Helou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.